F1000Research F1000Research 2046-1402 F1000 Research Limited London, UK 10.12688/f1000research.12170.1 Research Article Articles Diabetes & Obesity Methods of Clinical Decision-Making Social & Behavioral Determinants of Health Optimal cutoff for the evaluation of insulin resistance through triglyceride-glucose index: A cross-sectional study in a Venezuelan population

[version 1; peer review: 1 approved]

 Salazar Juan Formal Analysis Writing – Original Draft Preparation a 1 Bermúdez Valmore Conceptualization Writing – Review & Editing https://orcid.org/0000-0003-1880-8887 b 1 2 Calvo María Data Curation Investigation 1 Olivar Luis Carlos Data Curation Investigation 1 Luzardo Eliana Data Curation Investigation 1 Navarro Carla Data Curation Investigation 1 Mencia Heysa Investigation 1 Martínez María Data Curation Investigation 1 Rivas-Ríos José Investigation Writing – Original Draft Preparation 1 Wilches-Durán Sandra Funding Acquisition Writing – Review & Editing 2 Cerda Marcos Funding Acquisition Writing – Original Draft Preparation 2 Graterol Modesto Formal Analysis Funding Acquisition 2 Graterol Rosemily Funding Acquisition Writing – Original Draft Preparation 2 Garicano Carlos Investigation Writing – Original Draft Preparation 2 Hernández Juan Formal Analysis Investigation 2 Rojas Joselyn Conceptualization Writing – Review & Editing 1 3 Endocrine-Metabolic Research Center,, University of Zulia, Maracaibo, Venezuela Grupo de Investigación Altos Estudios de Frontera (ALEF), Simón Bolívar University, Cúcuta, Colombia Division of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, 02115, USA Jjsv18@gmail.com valmore@gmail.com

Competing interests: No competing interests were disclosed.

 7 8 2017 2017 6 1337 4 8 2017 Copyright: © 2017 Salazar J et al. 2017 This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Background: Insulin resistance (IR) evaluation is a fundamental goal in clinical and epidemiological research. However, the most widely used methods are difficult to apply to populations with low incomes. The triglyceride-glucose index (TGI) emerges as an alternative to use in daily clinical practice. Therefore the objective of this study was to determine an optimal cutoff point for the TGI in an adult population from Maracaibo, Venezuela.

Methods: This is a sub-study of Maracaibo City Metabolic Syndrome Prevalence Study, a descriptive, cross-sectional study with random and multi-stage sampling. For this analysis, 2004 individuals of both genders≥18 years old with basal insulin determination and triglycerides < 500 mg/dl were evaluated. A reference population was selected according to clinical and metabolic criteria to plot ROC Curves specific for gender and age groups to determine the optimal cutoff point according to sensitivity and specificity.The TGI was calculated according to the equation: ln [Fasting triglyceride (mg/dl) x Fasting glucose (mg/dl)]/2.

Results: The TGI in the general population was 4.6±0.3 (male: 4.66±0.34 vs. female: 4.56±0.33, p=8.93x10 -10). The optimal cutoff point was 4.49, with a sensitivity of 82.6% and specificity of 82.1% (AUC=0.889, 95% CI: 0.854-0.924). There were no significant differences in the predictive capacity of the index when evaluated according to gender and age groups. Those individuals with TGI≥4.5 had higher HOMA2-IR averages than those with TGI <4.5 (2.48 vs 1.74, respectively, p<0.001).

Conclusions: The TGI is a measure of interest to identify IR in the general population. We propose a single cutoff point of 4.5 to classify individuals with IR. Future studies should evaluate the predictive capacity of this index to determine atypical metabolic phenotypes, type 2 diabetes mellitus and even cardiovascular risk in our population.

 insulin resistance triglycerides glycemic Metabolic Syndrome Consejo de Desarrollo Científico, Humanístico y Tecnológico, Universidad del Zulia CC-0437-10-21-09-10 This work was supported by the Technological, Humanistic, and Scientific Development Council (Consejo de Desarrollo Científico, Humanístico y Tecnológico; CONDES), University of Zulia (grant nº CC-0437-10-21-09-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Abbreviations

Free Fatty Acids (FFA); Area under curve (AUC); Type 2 diabetes mellitus (DM2); Cardiovascular disease (CVD); Distance to ROC (DtR); Fasting Glucose (FG); Homeostasis Model Assessment (HOMA-IR); Insulinorresistance (IR); Youden Index (J), Metabolic Syndrome (MS); Triglyceride (TAG); Triglyceride - Glucose index (TGI)

 Introduction

Insulin resistance (IR) is a metabolic condition in which insulin-dependent tissues become less sensitive to insulin action, leading to an imbalance in the metabolism of carbohydrates, lipids and proteins 1 . This condition is caused by the influence of different risk factors in the population, such as aging, alcohol consumption, smoking, hypercaloric diets, sedentary lifestyle and obesity 2 . Its role in the development of different pathologies, as cardiovascular disease (CVD) 3 and cerebrovascular disease 4 , is now recognized, as well as playing an important role in the pathogenesis and clinical outcomes of the metabolic syndrome (MS) 5 and type 2 diabetes mellitus (DM2) 6 .

In 1963, Randle and colleagues were among the first to investigate the pathophysiology of IR 7 , suggesting the elevation of free fatty acids (FFA) in the splenic circulation as the cornerstone of this disorder. They proposed the glucose fatty acid cycle, called the Randle cycle. Years later, a theory proposed by Shulman 8 surfaced, which continued to support the role of FFA in the pathophysiology of IR. However, these authors suggested that FFA and its products, such as diacylglycerol, acyl-coA and ceramides, activate serin-threonine kinases, which phosphorylate important proteins, inhibit the insulin signaling pathway and subsequently translocated glucose transporter 4 (GLUT4) to the plasma membrane 8 .

Although many aspects remain to be clarified in the pathophysiology of IR, its long-term complications have generated great interest in the determination of ideal methods that allow the promotion of an early and accurate diagnosis in risky populations 9 . In this sense, the Euglycemic-Hyperinsulinemic Clamp is considered the gold standard for the determination of IR 10 , but the high cost and impracticability of this method has promoted the development of new techniques for the estimation of insulin sensitivity. Many mathematical models have been proposed in recent years with the objective of simplifying the measurement of IR 11 , highlighting the Homeostasis Model Assessment (HOMA-IR), a validated method to measure IR from serum glucose and fasting serum insulin 12 . This index has been studied in our population, which was conducted in 2026 subjects and evaluated the factors related to insulin resistance (defined as HOMA2-IR=2) 13 . However, one of the biggest limitations is the lack of accessibility to populations with lower incomes, since all the individuals require blood work to calculate the serum insulin.

Simental-Mendia et al. 14, 15 have proposed and validated a new formula to evaluate IR from the levels of serum triglycerides (TAG) and fasting glucose (FG), which is known as ‘Triglyceride/Glucose Index’ (TGI), this formula is a potential diagnostic tool when other standard methods are not available. Based on the information above, the objective of the study is to determine an optimal cut point of the TGI to determine IR and to evaluate the behavior according to the main sociodemographic characteristics in an adult population from Maracaibo, Zulia, Venezuela.

 Methods Sample selection and study design

The Maracaibo City Metabolic Syndrome Prevalence Study (MMSPS) study is a descriptive, cross-sectional, randomized, multi-stage sampling study that was carried out in Maracaibo-Venezuela; the second most populated city in the country with an approximate population of 2,500,000, in order to evaluate the cardiovascular and metabolic risk factors of this locality, during the period May 2007 - December 2009 16 . The only inclusion criteria was individuals older than 18 years. The sample (1,986 individuals) was calculated based on the estimates of the population in the city given by the National Institute of Statistics (1,428,043 inhabitants for 2007). A total of 244 individuals (12%) were added through oversampling, in order to increase the accuracy of the estimates obtained from the smaller subgroups of the sample, representing a total of 2230 individuals of both genders. Sampling details have been previously published 16 . The study was approved by the Bioethics Committee of the Endocrine and Metabolic Research Center – University of Zulia (approval number: BEC-006-0305). This ethical approval included all future studies that used the data from the MMSPS. All participants signed written consent before being questioned and physically examined by a trained team.

For this analysis, 2004 individuals were selected according to the availability of baseline insulin, in addition to the exclusion of individuals with TAG≥500 mg/dl. Based on this sub-sample, a reference population was selected based on the following criteria: abdominal obesity, total cholesterol, high blood pressure and personal history of DM2, coronary artery diseases, cardiac arrhythmias, acute cerebrovascular disease, and polycystic ovaries; with the purpose of establishing a subsample of healthy and sick subjects without using definitions or diagnostic criteria that include TAG and glycaemia values to avoid variables correlation a priori ( Figure 1).

Diagram of reference population selection for cut-off points determination of the triglyceride-glucose index in Maracaibo city, Venezuela.

ROC Curves: Receiver operating characteristic curves.

 Individual evaluation

The data was gathered through a complete medical history performed by the trained team: the past medical and family history for cardiovascular and endocrine-metabolic diseases was assessed.

 Blood pressure and anthropometric evaluation

The auscultation method was used for the measurement of blood pressure, using stethoscopes and calibrated sphygmomanometers adequately validated. The procedure was performed with the individual at rest (at least 15 minutes) and sitting with both feet on the floor; three measurements were taken, with 15 minutes of separation between one measurement and the other. Systolic blood pressure was determined by auscultation of the first Korotkoff noise, while diastolic blood pressure was determined on auscultation of the fifth Korotkoff noise.

Weight was determined through a dielectric balance (Tanita, TBF-310 GS Body Composition Analyzer, Tokyo, Japan), and height was obtained by using vertical tape calibrated in centimeters and millimeters. Individuals were standing and barefoot, with light clothing throughout the evaluation, maintaining a straight posture and head up. Body Mass Index was calculated using the weight/height formula and classified according to the criteria proposed by the World Health Organisation (low weight, normal weight, overweight, Obesity type I, II and III) 17 . The measurement of the abdominal circumference was taken with a plastic metric tape in centimeters at equidistant points between the costal ridge and the iliac crest, according to the protocol proposed by the National Salute Institute of the United States 18 . Abdominal obesity was defined according to specific cutoff points for our previously determined population, ≥90 cm in women and ≥95 cm in men 19 .

 Laboratory analysis

Overnight fasting determination of glucose, total cholesterol, triglycerides, and HDL-C was done with an automated analyzer (Human Gesellschaft fur Biochemica und Diagnostica mbH, Germany). The intra-assay variation coefficient for total cholesterol, TAG, and HDL-C was 3%, 5%, and 5%, respectively. Insulin was determined using an ultrasensitive ELISA double-sandwich method (DRG Instruments GmbH, Germany, Inc.), with a Detection Limit <1 mU/L. The HOMA2IR index was calculated using the software administered by the Oxford Diabetes Center, Endocrinology and Metabolism (available at http://www.dtu.ox.ac.uk/homacalculator/index.php). A cutoff value of ≥2 was used to determine IR 20 .

 Calculation of TGI

The calculation of the TGI was done using the equation: ln [Fasting TAG (mg/dl) x FG (mg/dl)]/2; thus being expressed on a logarithmic scale 14, 21 .

 Statistical analysis

Qualitative variables were expressed in absolute and relative frequencies. While the quantitative variables were expressed as arithmetic mean ± SD, with the previous analysis of normality through means of a Geary test. Significant differences between groups were assessed using the Student’s t-test, while an ANOVA was used for comparisons between three or more groups. Data were analyzed through the SPSS v.21 for Windows (IBM Chicago, IL), considering statistically significant results when p <0.05.

ROC curves were plotted in the reference population ( Figure 1) to analyze the predictive capacity and to determine an optimal cutoff point for the TGI. ROC curves were gender-specific using R version 3.4.1. Several indexes were calculated to evaluate the optimum cutoff point in the curve. The area under the curve (AUC) is used to establish the ability of the test to obtain an appropriate cutoff where an AUC of 1.00 is considered a perfect diagnostic test 22 . Comparisons between AUC were performed using Delong's test 23 . The Youden Index (J) was calculated using the formula [J = sensitivity + specificity-1 = S-(1-Es)] 23 , obtaining the value of true positives (sensitivity) and false positives (1-specificity) when J >1. The minimum cutoff point was calculated using the nearest point to 0.1 in the ROC curves formula: square root of [(1-sensitivity) 2 (1-specificity) 2] 24 . In addition, probability radius positive [sensitivity/1-specificity] and negative [1-sensitivity/specificity] were calculated to aid in the selection of the cutoff point together with the Youden index. Likelihood values >1 indicate association with the disease, while those <1 indicate association with the absence of the disease 25 .

 Results General characteristics of the sample

A total of 2004 individuals were studied, 53.4% (n = 1050) were female, the mean age of the population was 39.6±15.3. The general characteristics of the population are shown in Table 1. The mean TGI in the general population was 4.6±0.3, with higher values in males (males: 4.66±0.34 vs. females: 4.56±0.33, p=8.93x10 -10). The epidemiological behavior of the TGI according to age and ethnicity is shown in Table 2, which shows an increase of the index as age increases. In regards to ethnicity, no statistically significant differences were found between means (p=0.326).

General characteristics of the sample studied, Maracaibo city, Venezuela.
Female (n= 1050) Male (n=954) Total (n=2004)
n % n % n %
Age (years)
<30 308 29.3 363 38.1 671 33.5
30–49 420 40.0 350 36.7 770 38.4
≥50 322 30.7 241 25.3 563 28.1
Ethnicity
Mixed 794 75.6 740 77.6 1534 76.5
White Hispanic 171 16.3 145 15.2 316 15.8
Afro-Venezuelan 27 2.6 32 3.4 59 2.9
American Indian 47 4.5 36 3.8 83 4.1
Other * 11 1.0 1 0.1 12 0.6
Triglycerides (mg/dl)
<150 815 77.6 644 67.5 1459 72.8
≥150 235 22.4 310 32.5 545 27.2
Glycaemic status
Euglycemic 774 73.9 662 69.4 1436 71.7
Impaired fasting glucose 186 17.7 212 22.2 398 19.9
Type 2 diabetes mellitus 88 8.4 80 8.4 168 8.4

*Asian and Arabic descent.

Criteria according to the ADA 2016 consensus

 Epidemiological behavior of the triglyceride-glucose index in the general population according to sociodemographic variables, in Maracaibo city, Venezuela.
TOTAL (n=2004)
Mean±SD p *
Gender 8.93×10 −10
Female 4.56±0.33
Male 4.66±0.34
Age (years) 6.21×10 −77
<30 4.43±0.28
30-49 4.65±0.33
≥50 4.77±0.31
Ethnicity 0.326
Mixed 4.60±0.33
White Hispanic 4.62±0.35
Afro-Venezuelan 4.68±0.32
American Indian 4.60±0.31
Other 4.51±0.28

* Student’s t- test (for more than two groups one-way ANOVA was used).

¶ Asian and Arabic descent.

SD: standard deviation

Post-hoc Tukey: <30 years vs 30–49 years, p=5.09x10 −9; <30 years vs ≥50 years, p=5.09x10 −9; 30-49 years vs ≥50 years, p=5.10x10 −9.

When assessing the reference population (n=351); healthy: n=207 – sick: n=144, a similar behavior of the TGI was found according to age and ethnicity ( Table 3). In addition, there were no differences in TGI mean between the general and reference population.

Epidemiological behavior of the triglyceride-glucose index in the reference population according to sociodemographic variables, in Maracaibo city, Venezuela.
TOTAL (n=351)
n Mean±SD p *
Gender 5.83-10 -6
Female 190 4.41±0.29
Male 161 4.56±0.32
Age (years) 8.42×10 -28
<30 178 4.31±0.29
30–49 118 4.61±0.31
≥50 55 4.72±0.23
Ethnicity 0.413
Mixed 268 4.48±0.32
White Hispanic 52 4.48±0.34
Afro-Venezuelan 8 4.59±0.26
American Indian 20 4.39±0.23
Other 3 4.25±0.26

*Student’s t-test (for more than two groups one way-ANOVA was used).

¶ Asian and Arabic descent.

SD: Standard deviation.

Post-hoc Tukey: <30 years vs 30–49 years, p=5.09x10 -9; <30 years vs ≥50 years, p=5.09x10 -9; 30–49 years vs ≥50 years, p=0.03.

 Cutoff points for the TGI in the general population by gender

For the determination of cutoff points of the TGI, ROC curves were plotted for the general population by gender ( Figure 2). An AUC of 0.889 (95% CI: 0.854-0.924) was obtained for the general population with a proposed cutoff of 4.49 (82.6% sensitivity, and 82.1% specificity), while the AUC calculated for males was 0.903 (95% CI: 0.856-0.950) and for females was 0.871 (95% CI: 0.818-0.925); Delong's test: p=0.37. The cutoff points and index calculated according to the ROC curves are shown in Table 4.

Cut-off points for triglyceride-glucose index (TGI) selected in the general population and by gender, in Maracaibo city, Venezuela.
Gender TGI Sensitivity (%) Specificity (%) Youden index ROC distance LR+ AUC (95%CI)
Female 4.45 80.3 80.6 0.61 0.276 4.14 0.871 (0.818–0.925)
Male 4.51 87.2 83.1 0.70 0.212 5.15 0.903 (0.856–0.950)
Total 4.49 82.6 82.1 0.65 0.249 4.61 0.889 (0.854–0.924)

Cut-off points selected according to the best combination of indexes. Delong’s test= 0.37

 Receiver Operating Characteristic curves for the triglyceride-glucose index in the general population by gender, in Maracaibo city, Venezuela.

DtR, Distance to ROC; J, Youden Index; AUC, are under the curve; sen, sensitivity; spe, specificity.

 Cutoff points for the TGI in the general population by age

When assessing the predictive capacity of the TGI according to age, a higher AUC was obtained in individuals between the ages of 30 and 50 years old (AUC=0.876; 95% CI: 0.812-0.939); however, when comparing AUCs among age groups, no significant differences were found. The cutoff points and index calculated according to age are shown in Table 5, which are similar to that proposed for the general population (<30 years: 4.48 [65.0% sensitivity, and 84.8% specificity]; 30–50 years: 4.51 [84.7% sensitivity, and 78.3% specificity], ≥50 years, 4.51 [86.5% sensitivity, and 66.7% specificity]).

Cut-off points for triglyceride-glucose index (TGI) selected according to age groups, in Maracaibo city, Venezuela.
Age (years) TGI Sensitivity (%) Specificity (%) Youden index ROC distance LR+ AUC (95%CI)
<30 4.49 65.0 84.8 0.50 0.381 4.27 0.789 (0.684–0.895)
30-50 4.51 84.7 78.3 0.63 0.265 3.89 0.876 (0.812–0.939)
≥50 4.51 86.5 66.7 0.53 0.359 2.59 0.776 (0.602–0.949)

Cut-off points selected according to the best combination of indexes

Delong’s test: <30 vs 30–50 years; p=0.171. <30 vs >50 years; p=0.885. 30–50 vs >50 years; p=0.34.

 HOMA2IR according to cutoff points of the TGI

Finally, when assessing HOMA2-IR levels according to the proposed cutoff point of the TGI for the general population ( Figure 3), individuals with TGI≥4.5 exhibited higher levels of HOMA2IR than those who had a TGI <4.5 (2.48 vs 1.74, respectively, p<0.001), with similar behavior by gender.

HOMA2-IR levels according to the specific cut-off point for the triglyceride-glucose index in the general population, in Maracaibo city, Venezuela.

This data is available in both .SAV and .xls forms. BMI: Body Mass Index; BP: Blood Pressure.

 Discussion

The evaluation of IR is an objective that continues to acquire relevance in clinical and epidemiological research, due to the potential role of this disorder in the pathophysiology of MS 26 , the consequent risk of developing DM2 27 and CVD 28 . In developing countries with economic difficulties in health systems, such as Venezuela, routine measurements of plasma insulin are not easily accessible, which forces the use of other indexes based on the role of glucolipotoxicity as a key element in the development of IR 29 . In this way, the TGI has recently been proposed and validated as a useful alternative in clinical settings, and has been well accepted due to the high predictive power observed with respect to other indices 30 .

Several studies have shown that the TGI better predicts HOMA-IR levels than variables, such as the TAG/HDL index, visceral adiposity index, leptin, Apo-B/Apo-AI, and lipid parameters 29, 30 , representing a very good correspondence with this index 31 , which constitutes an important tool with high validity for the clinician when facing limited access to lab work-ups. However, in view of the wide variability of TAG levels according to the ethnic, sociocultural and genetic characteristics of each population, the need arises to evaluate their epidemiological behavior and establish reference values specific to each region.

In regards to our study, the mean TGI was higher in men compared to women. Several studies have reported similar findings 14, 32 ; however, when plotted ROC curves for the TGI for each gender, significant differences in the AUC values by gender were not observed. We propose the use of a single cutoff point of 4.5 for the identification of sick individuals in the clinical practice as an easy tool for the clinician.

These findings corresponded to those originally reported by the index’s authors in 2010 15 , when evaluating the discriminative ability of this index to determine IR against the euglycemic-hyperinsulinemic clamp in a population of 99 individuals (11 healthy, 34 obese, 22 with prediabetes and 32 with DM2) suggesting a cutoff point of 4.68 with high sensitivity (96.5%) and specificity (85.0%). Based on these findings, several studies have attempted to establish specific cutoff points for their populations, assessing the clinical utility of this index. In 2011, in a Brazilian population, Vasques et al. 33 stipulated that the TGI had a slightly better performance to diagnose IR compared to HOMA2-IR (AUC=0.79 vs AUC=0.77, respectively). Although these investigators did not perform any statistical tests to compare the diagnostic capacity between both indices, the similar behavior allows the use of TGI in clinical settings routinely.

On the other hand, Unger et al. 21 conducted a cross-sectional study in an Argentinean population with the aim of evaluating the discriminative capacity of the TGI for the diagnosis of MS, taking into account that the development of this syndrome is related to IR. They set a cutoff point of 8.8 (sensitivity = 79%, specificity = 86%) to diagnose MS in their population, a value that differs markedly from the values in our region and those originally proposed. These differences have been observed in other studies 34– 36 , so considering that the means of TAG do not vary significantly between these and our study, this discrepancy could be attributable to errors in the calculation of the original formula 37 .

In regards to age, an increase in the average TGI was observed as age increased, similar to that found by Navarro-González et al. 38 and Cuda et al. 39 . This can be associated with the increase in oxidative stress inherent to aging, which would favor the development of IR, as well as the elevation of plasma levels of TAG 40 . In this sense, Guerrero-Romero et al. 31 recently evaluated the performance of the TGI to determine IR against the euglycemic-hyperinsulinemic clamp in a young Mexican adult population (mean age: 19.2±1.4), with the goal of establishing a specific cutoff point in this population. However, the cutoff points of 4.55 in men and 4.68 in women were similar to the value proposed previously for the general population, and similar to the one proposed in our study. Also, when we plotted ROC curves for each age group, we did not observe significant differences between AUC, ruling out the need to establish age-specific cutoff points.

In relation to ethnicity, the small sample in each of the categories precludes the generalization of these results, but it shows that it is necessary to evaluate the behavior of the TGI in the different ethnic groups on a large scale and to determine if there are significant differences between them because there is no data reported on this diagnostic method among various ethnicities.

Base on previous analyzes, the usefulness of the TGI has been extended in several regions of the world, being also used in the screening of other pathological metabolic states in which the IR underlies the fundamental pathophysiological mechanism, such as DM2 41 and atypical metabolic phenotypes 42, 43 . In fact, the TGI appears to be a better predictor of incidence of DM2 than TAG 38 , weight gain 43 and other IR indices, such as TAG/HDL and HOMA-IR 41 . Moreover, Lee et al. performed a retrospective study involving 2900 Korean non-diabetic adults determinate as a cutoff point 8, (AUC=0.751, 95% CI 0.704-0.799) to predict the incidence of DM2 in their population. In addition, only individuals with a TGI >8.8 were associated with a significant risk of DM2 incidence, regardless of the presence of obesity 44 .

Additionally, the index can better predict the patient's metabolic status, as it has been shown in discriminating atypical metabolic phenotypes, such as metabolically obese normal weight and healthy obese, as well as their progression throughout time 35 . Cutoff points have been determined to discriminate these pathological metabolic status in two populations of Korea 34, 35 , which could facilitate the definition of these phenotypes. Future studies in our population should evaluate the utility of this index in the identification of these abnormal pathological statuses. It is important to mention that within the limitations of this study it is necessary to consider the transversal design and the lack of gold standard during the process of selection of the reference population.

 Conclusions

The TGI is an instrument of interest when it comes to identifying IR in the general population. We propose a single cutoff point of 4.5 to identify patients with IR, as we identify the need for generalization of the formula calculation in order to be able to adequately compare the differences observed in various studies. Despite this, due to the easier application in clinical practice, future studies in our population should evaluate the predictive capacity of this index to determine atypical metabolic phenotypes, DM2 and CVD risk.

 Data availability

The data referenced by this article are under copyright with the following copyright statement: Copyright: � 2017 Salazar J et al.

Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).

Dataset 1: Data for the study ‘Optimal cutoff for the evaluation of insulin resistance through triglyceride-glucose index: A cross-sectional study in a Venezuelan population’. This data is available in both .SAV and .xls forms. BMI: Body Mass Index; BP: Blood Pressure. doi, 10.5256/f1000research.12170.d171840 45

Wilcox G : Insulin and insulin resistance. Clin Biochem Rev. 2005;26(2):19–39. 16278749 1204764 Morigny P Houssier M Mouisel E : Adipocyte lipolysis and insulin resistance. Biochimie. 2016;125:259–66. 26542285 10.1016/j.biochi.2015.10.024 Patel TP Rawal K Bagchi AK : Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes. Heart Fail Rev. 2016;21(1):11–23. 26542377 10.1007/s10741-015-9515-6 Luchsinger J : Insulin resistance, type 2 diabetes, and AD: cerebrovascular disease or neurodegeneration? Neurology. 2010;75(9):758–759. 20739648 10.1212/WNL.0b013e3181eee287 Rojas J Bermúdez V Leal E : Insulinorresistencia E Hiperinsulinemia Como Factores De Riesgo Para Enfermedad Cardiovascular. AVTF. 2008;27(1):30–40. Reference Source Gastaldelli A : Role of beta-cell dysfunction, ectopic fat accumulation and insulin resistance in the pathogenesis of type 2 diabetes mellitus. Diabetes Res Clin Pract. 2011;93(suppl 1):S60–S65. 21864753 10.1016/S0168-8227(11)70015-8 Randle PJ Garland PB Hales CN : The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1(7285):785–789. 13990765 10.1016/S0140-6736(63)91500-9 Shulman GI : Cellular mechanisms of insulin resistance. J Clin Invest. 2000;106(2):171–6. 10903330 10.1172/JCI10583 314317 Borai A Livingstone C Kaddam I : Selection of the appropriate method for the assessment of insulin resistance. BMC Med Res Methodol. 2011;11(1):158. 22112229 10.1186/1471-2288-11-158 3258205 DeFronzo RA Tobin JD Andres R : Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214–223. 382871 Singh B Saxena A : Surrogate markers of insulin resistance: A review. World J Diabetes. 2010;1(2):36–47. 21537426 10.4239/wjd.v1.i2.36 3083884 Matthews DR Hosker JP Rudenski AS : Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9. 3899825 10.1007/BF00280883 Bermudez V Salazar J Martínez MS : Prevalence and Associated Factors of Insulin Resistance in Adults from Maracaibo City, Venezuela. Adv Prev Med. 2016;2016: 9405105. 27579182 10.1155/2016/9405105 4989131 Simental-Mendía LE Rodríguez-Morán M Guerrero-Romero F : The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304. 19067533 10.1089/met.2008.0034 Guerrero-Romero F Simental-Mendía LE González-Ortiz M : The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–51. 20484475 10.1210/jc.2010-0288 Bermúdez V Marcano RP Cano C : The Maracaibo city metabolic syndrome prevalence study: design and scope. Am J Ther. 2010;17(3):288–294. 20068446 10.1097/MJT.0b013e3181c121bc World Health Organization: Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. Geneva: The Organization;2000; 894:i–xii, 1–253. 11234459 Health Statistics: NHANES III reference manuals and reports (CDROM). Hyattsville, MD: Centers for Disease Control and Prevention,1996. Reference Source Bermúdez V Rojas J Salazar J : Optimal Waist Circumference Cut-Off Point for Multiple Risk Factor Aggregation: Results from the Maracaibo City Metabolic Syndrome Prevalence Study. Epidemiol Res Int. 2014;2014: 718571. 10.1155/2014/718571 Bermúdez V Rojas J Martínez MS : Epidemiologic Behavior and Estimation of an Optimal Cut-Off Point for Homeostasis Model Assessment-2 Insulin Resistance: A Report from a Venezuelan Population. Int Sch Res Notices. 2014;2014: 616271. 27379332 10.1155/2014/616271 4897148 Unger G Benozzi SF Perruzza F : Triglycerides and glucose index: a useful indicator of insulin resistance. Endocrinol Nutr. 2014;61(10):533–40. 25174769 10.1016/j.endonu.2014.06.009 Akobeng AK : Understanding diagnostic tests 3: Receiver operating characteristic curves. Acta Paediatr. 2007;66(5):644–7. 17376185 10.1111/j.1651-2227.2006.00178.x Demler OV Pencina MJ D'Agostino RB Sr : Misuse of DeLong test to compare AUCs for nested models. Stat Med. 2012;31(23):2577–87. 22415937 10.1002/sim.5328 3684152 Böhning D Böhning W Holling H : Revisiting Youden's index as a useful measure of the misclassification error in meta-analysis of diagnostic studies. Stat Methods Med Res. 2008;17(6):543–54. 18375457 10.1177/0962280207081867 Perkins NJ Schisterman EF : The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006;163(7):670–5. 16410346 10.1093/aje/kwj063 1444894 Samson SL Garber AJ : Metabolic syndrome. Endocrinol Metab Clin North Am. 2014;43(1):1–23. 24582089 10.1016/j.ecl.2013.09.009 Lyssenko V Jonsson A Almgren P : Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med. 2008;359(21):2220–2232. 19020324 10.1056/NEJMoa0801869 Miller M Stone NJ Ballantyne C : Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123(20):2292–2333. 21502576 10.1161/CIR.0b013e3182160726 Er LK Wu S Chou HH : Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals. PLoS One. 2016;11(3):e0149731. 26930652 10.1371/journal.pone.0149731 4773118 Du T Yuan G Zhang M : Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovasc Diabetol. 2014;13(1):146. 25326814 10.1186/s12933-014-0146-3 4209231 Guerrero-Romero F Villalobos-Molina R Jiménez-Flores JR : Fasting triglycerides and glucose index as a diagnostic test for insulin resistance in Young adults. Arch Med Rev. 2016;47(5):382–387. 27751372 10.1016/j.arcmed.2016.08.012 Irace C Carallo C Scavelli FB : Markers of insulin resistance and carotid atherosclerosis. A comparison of the homeostasis model assessment and triglyceride glucose index. Int J Clin Pract. 2013;67(7):665–672. 23758445 10.1111/ijcp.12124 Vasques AC Novaes FS de Oliveira Mda S : TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98–e100. 21665314 10.1016/j.diabres.2011.05.030 Lee SH Han K Yang HK : A novel criterion for identifying metabolically obese but normal weight individuals using the product of triglycerides and glucose. Nutr Diabetes. 2015;5(4):e149. 25915739 10.1038/nutd.2014.46 4423196 Lee SH Yang HK Ha HS : Changes in Metabolic Health Status Over Time and Risk of Developing Type 2 Diabetes: A Prospective Cohort Study. Medicine (Baltimore). 2015;94(40):e1705. 26448024 10.1097/MD.0000000000001705 4616763 Abbasi F Reaven GM : Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects: triglycerides × glucose versus triglyceride/high-density lipoprotein cholesterol. Metabolism. 2011;60(12):1673–1676. 21632070 10.1016/j.metabol.2011.04.006 Hosseini SM : Triglyceride-Glucose (TyG) Index Computation and Cut-Off. Acta Endo (Buc). 2015;11(1):130–131. 10.4183/aeb.2015.130 Navarro-González D Sánchez-Íñigo L Pastrana-Delgado J : Triglyceride-glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: The Vascular-Metabolic CUN cohort. Prev Med. 2016;86:99–105. 26854766 10.1016/j.ypmed.2016.01.022 Cuda G Lentini M Gallo L : Fasting triglycerides and glucose index in an unselected consecutive Italian population of outpatients. Riv Ital Med Lab. 2011;7(4):226–227. 10.1007/s13631-011-0032-3 Monickaraj F Aravind S Nandhini P : Accelerated fat cell aging links oxidative stress and insulin resistance in adipocytes. J Biosci. 2013;38(1):113–122. 23385819 10.1007/s12038-012-9289-0 Lee SH Kwon HS Park YM : Predicting the Development of Diabetes Using the Product of Triglycerides and Glucose: The Chungju Metabolic Disease Cohort (CMC) Study. PLoS One. 2014;9(2):e90430. 24587359 10.1371/journal.pone.0090430 3938726 Lee SH Han K Yang HK : Identifying subgroups of obesity using the product of triglycerides and glucose: the Korea National Health and Nutrition Examination Survey, 2008–2010. Clin Endocrinol (Oxf). 2014;82(2):213–220. 24841432 10.1111/cen.12502 Navarro-González D Sánchez-Íñigo L Fernández-Montero A : TyG Index Change Is More Determinant for Forecasting Type 2 Diabetes Onset Than Weight Gain. Medicine (Baltimore). 2016;95(19):e3646. 27175686 10.1097/MD.0000000000003646 4902528 Lee DY Lee ES Kim JH : Predictive value of triglyceride glucose index for the risk of incident diabetes: A 4-year retrospective longitudinal study. PLoS One. 2016;11(9):e0163465. 27682598 10.1371/journal.pone.0163465 5040250 Salazar J Bermúdez V Calvo M : Dataset 1 in: Optimal cutoff for the evaluation of insulin resistance through triglyceride-glucose index: A cross-sectional study in a Venezuelan population. F1000Research. 2017. Data Source 10.5256/f1000research.13172.r25043 Reviewer response for version 1 Benozzi Silvia Fabiana 1 Referee Unger Gisela 1 Co-referee Universidad Nacional del Sur, Bahía Blanca, Argentina

Competing interests: No competing interests were disclosed.

 25 8 2017 Copyright: © 2017 Benozzi SF and Unger G 2017 This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. recommendation approve

This research article deals with an interesting subject related to insulin resistance, its evaluation without the need of an insulin blood test. We believe that it can contribute to identify patients with metabolic risk. Authors have clearly elaborated the background of the problem and current literature is cited. The study is properly conducted and described. But, there are some shortcomings that should be corrected:

Abstract: Line 1, there are two dots after the word evaluated.

Keywords are absent.

Abbreviations: Page 3, we considered unnecessary this subtitle because the abbreviations are spelled out in the text.

Sample selection and study design: We have interpreted that the presence of all the cited criteria was necessary to classify an individual in the reference population, but it is not clear in the text. Authors should explain how many of the cited criteria were considered to classify an individual as healthy or sick.

Figure 1: Authors should consider the previous correction also in this figure. Authors should replace the explanation †Abdominal circumference > 90 cm in the female sex and > 95 cm in the male secx with † Abdominal obesity defined as: abdominal circumference > 90 cm in the female sex and > 95 cm in the male sex. Authors should highlight in the respective box that the population of 2004 individuals is the General population.

Laboratory analysis: If possible, authors should provide the fasting time in hours owing the lack of harmonization in this preanalytical aspect worldwide. Glucose and insulin analytical coefficients of variation should be provided. It is not necessary HDL-C description as this analyte was not used in the present research.

Statistical analysis: Authors should verify the ROC curve formula described to calculate the minimum cutoff point.

Results: Authors should correct the second subtitle because the cutoff points were calculated in the reference population (n=351) – as stated in Methods – and not in the general population (n=2004); also in the second line of the respective text. Authors should correct the third subtitle because the cutoff points were calculated in the reference population (n=351) – as stated in Methods – and not in the general population (n= 2004); authors should clarify the comparison made in line 7 of the respective text, we understand that they are comparing the cutoff values obtained by age with the cutoff value obtained for the total reference population.

Table 2: Authors should replace the word TOTAL with TGI so as to allow a better interpretation of the values shown in the table. Also the number of individuals should be described by variable, as in Table 3.

Table 3: Authors should replace the word TOTAL with TGI so as to allow a better interpretation of the values shown in the table.

Table 4: Authors should correct the table title because the cutoff points were calculated in the reference population (n=351) – as stated in Methods – and not in the general population (n= 2004).

Table 5: Authors should indicate in the title that the cutoff points were calculated in the reference population (n= 351),as in the other tables.

Figure 2: Authors should correct the title because the cutoff points were calculated in the reference population (n=351) – as stated in Methods – and not in the general population (n= 2004).

Figures and tables in general: Authors should verify that each figure or table has a concise title of no more than 15 words. Authors should provide a legend for each figure and table that briefly describes the key points and explain any symbols and abbreviations used. Also the n value should be provided in each table and figure to help reader’s interpretation.

Discussion: Authors states that TGI was higher in men compared to women, and that an increase in its average value was observed as age increased. It would be interesting to evaluate the effect size of these statistical differences so as to interpret the clinical importance of these increases;Cohen’s d─https://www.uccs.edu/~lbecker/─ can be used for this purpose if the variable has a parametric distribution.

General considerations: Authors should express p values with three decimals in all the text, tables and figures. The word  cutoff is written as cut-off in same parts of the text, figures and tables, the same happens with the word  indexes and  indices. They should be written in the same way in all the text. It would be advisable to replace in the introduction: blood work to calculate the serum insulin with insulinblood test; in all the text: sick with unhealthy; in the conclusions: generalization with harmonization or standardization.

Is the work clearly and accurately presented and does it cite the current literature?

Partly

If applicable, is the statistical analysis and its interpretation appropriate?

Yes

Are all the source data underlying the results available to ensure full reproducibility?

Yes

Is the study design appropriate and is the work technically sound?

Yes

Are the conclusions drawn adequately supported by the results?

Yes

Are sufficient details of methods and analysis provided to allow replication by others?

Yes

Reviewer Expertise:

NA

We confirm that we have read this submission and believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.